REGENXBIO Inc (RGNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

9600 BLACKWELL ROAD ROCKVILLE, MD 20850

REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.

Data as of 2020-09-12
Market Cap1.008 Billion Shares Outstanding37.334 Million Avg 30-day Volume311.289 Thousand
P/E Ratio Dividend Yield EPS-3.65
Price/Sales16.619 Price cash flow ratio95.9 Price free cash flow ratio-8.4
Book Value10.66 Price to Tangible Book2.6 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.036363
BETA0.900159 52-week High/Low54.97 / 20.03 Stddev0.202113

Are you looking for this stock instead?

View SEC Filings from RGNX instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 4 0.0% 1 (0.07%) 0 (0.0%)
Funds Holding: 175 167 4.79% 44 (2.87%) 40 (2.56%) 10.0%
13F shares: 29.009 Million 28.581 Million 1.5% 7.977 Million 7.78 Million 2.53%
% Ownership 77.7023 76.8591 1.1% 21.3664 20.9212 2.13%
New Positions: 26 22 18.18% 10 11 -9.09%
Increased Positions 70 52 34.62% 18 10 80.0%
Closed Positions 16 37 -56.76% 6 12 -50.0%
Reduced Positions 49 61 -19.67% 9 12 -25.0%
Total Calls 144.233 Thousand 171.349 Thousand -15.83% 17.2 Thousand 56.3 Thousand -69.45%
Total Puts 107.603 Thousand 187.796 Thousand -42.7% 16.3 Thousand 38.7 Thousand -57.88%
PUT/CALL Ratio 0.75 1.1 -31.82% 0.95 0.69 37.68%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RGNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FOX ALLAN M.

  • Director
4,367,678 2020-07-27 2

VASISTA VITTAL CHIEF FINANCIAL OFFICER

195,024 2020-07-15 9

KARABELAS ARGERIS N

0 2020-05-29 1

HAYDEN DONALD J JR

0 2020-05-29 5

BESHAR LUKE M

0 2020-05-29 1

STUMP DAVID C

0 2020-05-29 1

ABDUN-NABI DANIEL

0 2020-05-29 1

TASSE DANIEL

0 2020-05-29 1

GLUCKSMANN ALEXANDRA

0 2020-05-29 1

SIMPSON CURRAN SVP, PRODUCT DEVELOPMENT & CTO

3,948 2020-02-10 5

MILLS KENNETH T. PRESIDENT AND CEO

0 2020-01-02 2

CHRISTMAS PATRICK J. SVP, GENERAL COUNSEL

0 2020-01-02 1

DANOS OLIVIER CHIEF SCIENTIFIC OFFICER

0 2020-01-02 1

PAKOLA STEVE CHIEF MEDICAL OFFICER

0 2020-01-02 1

YOO STEPHEN CHIEF MEDICAL OFFICER

0 2018-12-03 0

ALI FARAZ CHIEF BUSINESS OFFICER

  • Officer
0 2017-01-04 0

SAMUELS CAMILLE D

  • Director
0 2016-06-01 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2016-05-17 0

ENGLEMAN EDGAR

  • Director
940,449 2015-09-22 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD INTERNATIONAL MASTER FUND, L.P.

DEERFIELD PARTNERS, LP

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-09-22 0

FLYNN JAMES E

DEERFIELD MGMT III, L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
0 2015-09-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FOX ALLAN M. - Director by the allan m. fox revocable trust

2020-09-18 16:37:20 -0400 2020-08-06 G 90,000 d 1,324,110 indirect

FOX ALLAN M. - Director by the harriette b. fox revocable trust

2020-09-18 16:37:20 -0400 2020-08-06 G 90,000 a 315,000 indirect

FOX ALLAN M. - Director by the allan m. fox revocable trust

2020-09-18 16:37:20 -0400 2020-07-27 G 225,000 d 1,414,110 indirect

FOX ALLAN M. - Director by the harriette b. fox revocable trust

2020-09-18 16:37:20 -0400 2020-07-27 G 225,000 a 225,000 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments